Small Business Innovation Research (SBIR) Small Business Technology Transfer (STTR)
spacer
Ethel Rubin
Ethel Rubin is a technology commercialization and investment executive who leads new initiatives in the biomedical technology industry and decision making for new venture investments. She has led teams and initiatives in both large global and early stage companies that led to significant value creation. In her current role as Entrepreneur in Residence at the NIH and Maryland’s BioHealth Innovation, her efforts cross the funding spectrum, preparing companies for seed - series A financing, mentoring CEOs on corporate and product development strategies, while connecting VCs and Corporate Ventures with companies developing technologies of interest. 
 
 
As a Life science “Shark" Dr. Rubin works with bio and med tech companies to raise funds while progressing their product development to significant inflection points and preparation for product launch. She has held corporate leadership roles in global clinical strategy and medical affairs at Medtronic, plc, was Chief Scientific Officer of two startup companies, is President of life sciences business development advisory firm Innovative BioStrategies, LLC, and a venture partner at FundRx. She has worked on over 25 products in the marketplace garnering 9 figure sales revenue, was instrumental in 3 M&As, multiple partnerships/academic collaborations, and coaches over 50 CEOs in preparation for private financing each year. Representative companies include regenerative and precision medicine, hematology, NASH, obesity and metabolic disease drugs, minimally invasive cardiac interventional, imaging and surgical devices, gene therapy for rare diseases. 
 
Dr. Rubin holds a PhD in Biochemistry and Biophysics from the University of Rochester School of Medicine & Dentistry and obtained a certificate in Board of Directors governance from The George Washington University School of Business. She was a postdoctoral fellow in Molecular Oncology at The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins where her work focused on breast cancer development & progression and has held numerous leadership roles in organizations as diverse as Women In Bio and The Emerging Technology Centers in Baltimore.  She is an invited speaker, panelist or moderator at numerous innovation and investment conferences and an active blogger and contributor  to public forums. Check out her posts at www.linkedin.com/in/ethelrubinphd.
 
Current participants in NIH’s EIR Pilot